Carrier detection in a mucopolysaccharidosis type II family (Hunter disease) allowed the identification of germline and somatic mosaicism in the patient's mother: the R443X mutation was found in a varying proportion in tested tissue (7% in leucocytes, lymphocytes, and lymphoblastoid cells, and 22% in fibroblasts). The proband's sister carries the at risk allele (determined by haplotype analysis), but not the mutation. In sporadic cases of X linked diseases, germline mosaicism of the proband's mother is difficult to exclude and should be considered in genetic counselling.
Hunter disease or mucopolysaccharidosis type II (MPS II) is an X linked lysosomal storage disease resulting from the deficiency of iduronate-2-sulphatase (IDS, EC 3.1.6.13). ' The IDS gene has been mapped to Xq28.2 A full length cDNA clone containing an open reading frame of 1650 bp has been isolated and sequenced. 3 The IDS gene spans 24 kb and contains nine exons4 5 and has been completely sequenced6 (GenBank accession number L4358 1). A pseudogene located 20 kb distal to the active gene has been characterised6 and is involved in recombinations with the IDS gene. 7 8 Various IDS locus alterations have been described,9'-2 such as large deletions and rearrangements, but about 80% of the mutations are point mutations, minor deletions, or insertions. Most of them are private except for some that more frequently occur on CpG dinucleotides.
Female carriers of MPS II are asymptomatic though they often show decreased levels of IDS activity in serum or leucocytes or both. Cloned fibroblasts'3 or hair roots'4 have also been studied for carrier detection. However, attempts to identify carriers by enzyme assays have often led to ambiguous results because of nonrandom X inactivation. Indirect genotype analysis using intragenic and closely linked flanking polymorphisms, combined with enzymatic and pedigree analyses, allows carrier detection in some but not all families. '5 Quantitative PCR To assess the relative proportion of mutant (R443X) and normal DNA, exon 9 was amplified as described previously for 29 cycles, and 1 jCi of '32P-dCTP was added before the last cycle. Radiolabelled PCR products were digested by TaqI and separated on an 8% acrylamide non-denaturing gel. The gel was dried and autoradiographed. Radioactivity of each band was quantified by scanning the film. Then the bands were cut from the dried gel and radioactivity content estimated by scintillation counting.
Results

IDS ACTIVITY
IDS activity was borderline in the mother's leucocytes and within the normal range in serum and lymphoblastoid cells (table 1) . IDS activity was found to be normal in the grandmother's leucocytes and serum and in the sister's lymphoblastoid cells. Study of 25 fibroblast clones from the sister did not show any deficient clone (data not shown).
HAPLOTYPE ANALYSIS
The results of haplotype analysis are shown in fig 1: microsatellite DXS 1 1 13 was the only informative marker. Unexpectedly, the patient's sister had inherited from her mother the same X chromosome as her brother.
MUTATION R443X
Exon 9 was systematically sequenced (presence of several mutational hot spots9 10 12 ), allowing the identification of the R443X mutation in the patient's genomic DNA. The presence of this mutation was tested in the mother's leucocytes by TaqI digestion of exon 9 PCR product: this showed an abnormal distribution of digested and undigested PCR products (not shown). The mother's genomic DNA extracted from various sources (leucocytes, lymphocytes, lymphoblastoid cells, fibroblasts, and hair roots) was analysed by ASO hybridisation to test the hypothesis of somatic mosaicism: the mutant allele was present with a low and varying intensity (fig 2) . The mutation was not detected in the grandmother's leucocytes nor in the leucocytes of the sister who had inherited the at risk haplotype.
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